GSA Capital Partners’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,372
Closed -$124K 2046
2025
Q4
$124K Buy
+33,372
New +$286K 0.01% 1507
2025
Q3
Sell
-25,599
Closed -$492K 1968
2025
Q2
$492K Sell
25,599
-1,782
-7% -$27.8K 0.03% 932
2025
Q1
$303K Sell
27,381
-36,582
-57% -$436K 0.03% 1146
2024
Q4
$1.06M Sell
63,963
-10,144
-14% -$127K 0.08% 367
2024
Q3
$753K Buy
74,107
+66,875
+925% +$1.99M 0.06% 641
2024
Q2
$418K Sell
7,232
-28,806
-80% -$1.41M 0.03% 1076
2024
Q1
$1.2M Buy
36,038
+1,750
+5% +$88.6K 0.1% 327
2023
Q4
$2.78M Buy
34,288
+28,657
+509% +$2.33M 0.23% 41
2023
Q3
$919K Buy
5,631
+4,388
+353% +$1.04M 0.08% 448
2023
Q2
$408K Sell
1,243
-2,530
-67% -$772K 0.04% 859
2023
Q1
$1.04M Buy
+3,773
New +$1.39M 0.1% 293
2022
Q4
Sell
-1,074
Closed -$257K 1770
2022
Q3
$257K Buy
+1,074
New +$288K 0.03% 1034
2021
Q4
Sell
-414
Closed -$307K 1682
2021
Q3
$307K Buy
+414
New +$282K 0.03% 1000

Other funds holding OM

GSA Capital Partners's OM Position: Q1 2026 in Review

GSA Capital Partners sold out of Outset Medical (OM) in Q1 2026, closing a stake of 33,372 shares — an estimated $124K sold.

GSA Capital Partners first reported a position in OM in Q3 2021 and held it in 13 quarters. The position peaked at $2.78M in Q4 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • GSA Capital Partners reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 33,372 Outset Medical shares in Q1 2026, an estimated $124K.
  • GSA Capital Partners first reported a position in Outset Medical in Q3 2021 and held it in 13 quarters.
  • GSA Capital Partners's Outset Medical position peaked at $2.78M in Q4 2023.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.